This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Careers | Join | About | Print Page | Report Abuse | Sign In
SCCT Innovation Series
Share |


After careful consideration, SCCT has decided to reschedule the AI and ML in Cardiovascular CT meeting, originally planned for April 24 – 26, 2020 in New York City. The in-person meeting will be rescheduled for April 2021 and will remain in New York. 

To ease the impact on your educational goals, SCCT will be presenting selected sessions of the AI and ML in CCT meeting online. On Friday, April 24, watch featured speakers present developments in AI and ML that have the potential to impact cardiovascular medicine and cardiovascular CT from the comfort of your office or home. Faculty will be available to answer your questions following each session.

Our decision to reschedule was not taken lightly. The health, well-being and safety of our attendees, faculty and staff is of the utmost priority. SCCT has been closely monitoring updates and recommendations from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), as well as state and local governments. In the last week, we have also learned of the increasing number of travel advisories and restrictions being placed on health care providers and staff of hospitals and institutions in the U.S. and globally.

Questions? Please email

Learn more about the online event


About AI & Ml in CCT

We are witnessing an era of accelerated development of advanced artificial intelligence (AI) and machine learning (ML) techniques designed to maximize data extraction from conventional cardiac imaging. These applications offer the potential for scientific advancement and improved patient care. 

The SCCT Innovation Series will bring together AI/ML developers, the clinical cardiac CT community and other relevant stakeholders to discuss the development, validation and clinical implementation of these technologies in cardiovascular medicine. 

Designed to promote intensive interaction in an informal way, this meeting will include hands-on workshop experience in data and image analysis with AI/ML tools, lectures from experts in the field and round-table discussion.

Register now


Program content

This meeting will focus on developments in AI and ML, that have the potential to impact on cardiovascular medicine and cardiovascular CT. Recognizing that within these boundaries the potential of these technologies is still broad, we will focus in this first meeting on the theme of coronary artery disease, allowing for an in-depth discussion on clinical applications of these technologies with a wide range of stakeholders from clinical, academic and commercial arenas. 

Themes for future meeting themes would include wider clinical applications of these technologies in the areas of structural. congenital, heart muscle and electrical heart disease.



View program

Rajesh Dash, PhD    Ed Nicol, MD, MBA, FSCCT
Bruno DeMan
   Koen Nieman, MD, PhD
Damini Dey, PhD, FSCCT
   Anders Persson, MD, PhD
Leo Grady 
   Julie Pekarek
Saurabh Jha, MD
   Daniel Rubin, MD, MS
Charles Kahn, MD
   Partho Sengupta
Marton Kolossvary, MD
   Puneet Sharma
James Kuht, MD
   Leslee Shaw, PhD, MSCCT
Michael Lu, MD
   Jeff Sorenson
Ken Mahaffey, MD
   CharleyTaylor, PhD
Maulik Majmudar, MD
   Thanasis Tsanas
Michael McConnell, MD
   Michelle Williams, MD, PhD, FSCCT
James Min, MD, MSCCT
   Andrew Williams




Abstract submission is closed.

Abstracts are invited on the topic of Practical and ethical challenges in machine learning/AI and their solutions.

Do you have an experience of developing a machine learning/AI solution for an aspect of cardiovascular computed tomography? What were the practical or ethical challenges that you faced and how did you overcome these? We are looking for interesting abstracts from clinical medicine, research or industry that discuss these issues.

Requirements: Abstracts should be 250 words long and consist of text only (no figures or tables).

Format: Accepted abstracts will be invited to present a 15 minute talk about their experiences at the SCCT Innovation meeting. Abstracts will be held Saturday, April 25 for 1:30 to 3pm. 

Key dates for the Innovation Series 2020 abstract program

Nov. 8, 2019 Abstract submission opens
Jan. 13, 2020 Abstract submission closes
Early Feb. 2020 Notifications sent to First Authors
Mid-Feb. 2020 Abstract acceptance/decline deadline


Commercial Relationship Disclosure Procedures

  • All financial relationships with commercial interests relevant to the research reported in the abstract must be disclosed.
  • As the First Author, it is your responsibility to provide all commercial relationship disclosures for yourself, your spouse/partner and each of your co-authors during the abstract acceptance process.
  • Relevant non-remunerative positions that may create a conflict of interest must also be reported.

Registration includes coffee breaks and Saturday lunch.

Status  Advanced rate  Late/Onsite rate 
 Member  $495  $595
 Non-member  $495  $595
 Fellows and residents  $195  $295
 Technologists  $195  $295


Register now


Organizing committee

Ed Nicol, MD, MBA, FSCCT
Koen Nieman, MD, PhD, FSCCT
Michelle Williams, MD, PhD, FSCCT


Hotel and Travel

New York Marriott East Side
525 Lexington Avenue at 49th Street
New York, NY 10017

SCCT Rate: $219
Destination Fee: $25 per night per room
Cut-off date: March 23, 2020


Book your room


Cancellation Policy

The registration fees for all workshops, academies and symposium are non-refundable or transferable.

Cancellation of conference or meeting registration does not constitute a cancellation of your hotel room. Please be sure to handle both separately. 


Sponsorship Opportunities 

Why Sponsor?
As a sponsor of the Innovation Meeting Series, your company will be seen as leaders and supporters at the forefront of this networking, road testing and collaboration engagement project. Sponsoring this meeting offers a competitive advantage at a time of significant interest. SCCT has defined the three levels of sponsorship for this meeting. The levels of recommended sponsorship benefits are designed to increase the exposure and positioning of your company. The more you choose to support, the higher your level and increased visibility throughout the meeting.

Interested in becoming a sponsor?


Sponsor Benefits